← Back to directory

Annalisa Capuano

Researcher Next ID · RN-042789

Researcher · Medicine

University of Campania "Luigi Vanvitelli"

Caserta, New Zealand

Accepting doctoral researchersFunding unknown
Works count
356
Citation count
9,256
H-index
50
i10-index
214

Research interests

Medicine
Pharmacology, Toxicology and Pharmaceutics
Pharmacovigilance and Adverse Drug Reactions
Diabetes Treatment and Management
Pharmaceutical studies and practices
SARS-CoV-2 and COVID-19 Research
Drug-Induced Adverse Reactions

Publications

  • Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

    Frontiers in Drug Safety and Regulation · 2024 · https://doi.org/10.3389/fdsfr.2023.1323057

  • Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes

    Pharmacological Research · 2022 · 10.1016/j.phrs.2022.106448

  • Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment

    Pharmacological Research · 2022 · 10.1016/j.phrs.2022.106062

  • COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety

    Drug Safety · 2021 · 10.1007/s40264-021-01131-6

  • Current and future therapeutic perspective in chronic heart failure

    Pharmacological Research · 2021 · 10.1016/j.phrs.2021.106035

  • COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety

    Drug Safety · 2021 · 10.1007/s40264-021-01131-6

  • Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations

    Expert Review of Vaccines · 2020 · 10.1080/14760584.2020.1825951

  • Current pharmacological treatments for COVID‐19: What's next?

    British Journal of Pharmacology · 2020 · https://doi.org/10.1111/bph.15072

  • Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium

    Pharmacological Research · 2020 · 10.1016/j.phrs.2020.104781

  • SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment

    International Immunopharmacology · 2020 · 10.1016/j.intimp.2020.106519

  • Covid-19 Kills More Men Than Women: An Overview of Possible Reasons

    Frontiers in Cardiovascular Medicine · 2020 · 10.3389/fcvm.2020.00131

  • Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials

    Diabetes Care · 2017 · 10.2337/dc16-1957

  • Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis

    Endocrine · 2013 · https://doi.org/10.1007/s12020-013-9939-5

  • Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysis

    Journal of Endocrinological Investigation · 2013 · 10.1007/bf03346748

  • Metabolic syndrome and endometrial cancer: a meta-analysis

    Endocrine · 2013 · 10.1007/s12020-013-9973-3

  • Metabolic syndrome and postmenopausal breast cancer

    Menopause The Journal of The North American Menopause Society · 2013 · 10.1097/gme.0b013e31828ce95d

  • New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities

    Bioorganic & Medicinal Chemistry · 2005 · https://doi.org/10.1016/j.bmc.2005.10.064

Current projects

    No projects listed.